Thomas J Schnitzer

Finished

Prot #R475-OA-1816: Study to Evaluate Arthroplasty Specimens in the Phase 3 Fasinumab Program for Osteoarthritis of the Knee and Hip

Schnitzer, T. J. (PD/PI)

ICON Clinical Research Limited, Regeneron Pharmaceuticals, Inc.

5/14/19 → 5/14/22

Project: Research project

Prot #R475-OA-1758: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Effects of Fasinumab on Peripheral Nerve Function in Patients with Pain due to Osteoarthritis of the Hip or Knee

Schnitzer, T. J. (PD/PI)

inVentiv Health Clinical, Regeneron Pharmaceuticals, Inc.

2/21/19 → 2/21/24

Project: Research project

Prot #FX006-2018-015: A Randomized, Double-Blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of FX006 in Patients with Hip Osteoarthritis

Schnitzer, T. J. (PD/PI)

Flexion Therapeutics, Inc.

2/6/19 → 2/6/22

Project: Research project

Main Project

Apkarian, A. (PD/PI), Griffith, J. W. (Co-Investigator), Kahnt, T. (Co-Investigator), Manning, D. W. (Co-Investigator), Parrish, T. B. (Co-Investigator) & Schnitzer, T. J. (Co-Investigator)

National Institute of Arthritis and Musculoskeletal and Skin Diseases

2/1/19 → 12/31/24

Project: Research project

(PRESPEND) Prot #R475-OA-1815: Study to Evaluate Synovial Fluid in the Phase 3 Fasinumab Program for Osteoarthritis of the Knee and Hip

Schnitzer, T. J. (PD/PI)

ICON Clinical Research Limited, Regeneron Pharmaceuticals, Inc.

1/24/19 → 1/24/20

Project: Research project

Prot #CL2-201086-002/GLPG1972-CL-201: Efficacy and safety of 3 doses of S201086/GLPG1972 administered orally once daily in patients with knee osteoarthritis. A 52-week international, multi-regional, multi-center, randomized, double-blind, placebo-controll

Schnitzer, T. J. (PD/PI)

Medpace Clinical Research LLC, Galapagos NV

12/4/18 → 12/4/21

Project: Research project

Center for chronic pain and drug abuse

Apkarian, A. (PD/PI), Apkarian, A. (PD/PI), Apkarian, A. (PD/PI), Cox, J. M. (Co-Investigator), Cox, J. M. (Co-Investigator), Cox, J. M. (Co-Investigator), Drenan, R. M. (Co-Investigator), Graves, S. M. (Co-Investigator), Griffith, J. W. (Co-Investigator), Griffith, J. W. (Co-Investigator), Griffith, J. W. (Co-Investigator), Huang, L. (Co-Investigator), Jovasevic, V. (Co-Investigator), Miller, R. J. (Co-Investigator), Parrish, T. B. (Co-Investigator), Parrish, T. B. (Co-Investigator), Parrish, T. B. (Co-Investigator), Procissi, D. (Co-Investigator), Procissi, D. (Co-Investigator), Procissi, D. (Co-Investigator), Rodes, M. E. (Co-Investigator), Schnitzer, T. J. (Co-Investigator), Schnitzer, T. J. (Co-Investigator), Schnitzer, T. J. (Co-Investigator), Awatramani, R. (Other), Martina, M. (Other), Radulovic, J. (Other) & Surmeier Jr, D. J. (Other)

National Institute on Drug Abuse

9/1/18 → 6/30/25

Project: Research project

Prot# BA058-05-019: A Randomized, Double-blind, Placebo-controlled, Phase 3 Multicenter Study to Evaluate the Safety and Efficacy of Abaloparatide-SC for the Treatment of Men with Osteoporosis

Schnitzer, T. J. (PD/PI)

ICON Clinical Research, LLC, Radius Health, Inc.

6/13/18 → 6/13/25

Project: Research project

Prot #R475-OA-1611: A Phase 3 Randomized, Double-Blind, Multi-Dose, Placebo and Naproxen-Controlled Study to Evaluate the Efficacy and Safety of Fasinumab in Patients with Pain Due to Osteoarthritis of the Knee or Hip

Schnitzer, T. J. (PD/PI)

ICON Clinical Research Limited, Regeneron Pharmaceuticals, Inc.

10/25/17 → 11/25/23

Project: Research project

D-Cycloserine for the Treatment of Chronic, Refractory Low Back Pain

Schnitzer, T. J. (PD/PI), Apkarian, A. (Co-Investigator) & Griffith, J. W. (Co-Investigator)

U.S. Army Medical Research and Materiel Command

9/30/17 → 9/29/24

Project: Research project

Prot #KF7013-03: Open-label safety trial of intravenous neridronic acid in subjects with complex regional pain syndrome (CRPS)

Schnitzer, T. J. (PD/PI)

Worldwide Clinical Trials, Inc., Grunenthal GmbH

1/17/17 → 1/17/22

Project: Research project

Increasing Bone Mass and Bone Strength in Individuals with Chronic Spinal Cord Injury: Maximizing Response to Therapy

Schnitzer, T. J. (PD/PI)

U.S. Army Medical Research and Materiel Command

9/30/16 → 3/29/19

Project: Research project

Prot #A4091056: A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of the Analgesic Efficacy and Safety of a Dose Titration Regimen for the Subcutaneous Administration of Tanezumab in Subjects with Osteoarthritis of the Hip or Knee

Schnitzer, T. J. (PD/PI)

INC Research, LLC, Pfizer Inc.

8/2/16 → 8/2/19

Project: Research project

Cortico-striatal plasticity in the transition to chronic pain

Apkarian, A. (PD/PI), Griffith, J. W. (Co-Investigator), Martina, M. (Co-Investigator), Parrish, T. B. (Co-Investigator), Procissi, D. (Co-Investigator), Schnitzer, T. J. (Co-Investigator) & Surmeier Jr, D. J. (Co-Investigator)

National Institute of Dental and Craniofacial Research

7/1/16 → 12/31/18

Project: Research project

Brain mechanisms for clinical placebo in chronic pain

Apkarian, A. (PD/PI), Cella, D. (Co-Investigator), Gershon, R. (Co-Investigator), Parrish, T. B. (Co-Investigator), Schnitzer, T. J. (Co-Investigator) & Griffith, J. W. (Other)

National Center for Complementary and Integrative Health

6/1/16 → 5/31/18

Project: Research project